The National Company Law Appellate Tribunal (NCLAT) has ordered Modi Lifecare Industries to pay 6.3 million rupees to Lyka Labs Limited within 30 days. Overturning a lower NCLT dismissal, the bench ruled that admitted royalty debts under a technical agreement are enforceable, and failure to pay will trigger corporate insolvency.
NEW DELHI — In a major victory for corporate debt enforcement, the National Company Law Appellate Tribunal (NCLAT) has ruled in favor of Mumbai-headquartered pharmaceutical manufacturer Lyka Labs Limited. The appellate court issued a strict tribunal order mandating Ahmedabad-based Modi Lifecare Industries Limited to clear a default balance of 6.3 million rupees (₹63 lakh) within 30 days. This directive completely reverses a prior ruling by the lower adjudicating authority that had initially dismissed the debt recovery petition.
NCLAT Overturns Rejection of Insolvency Action
The judicial intervention stems from a long-running corporate feud regarding an operational debt accrued under a commercial Technical Guidance Agreement (TG Agreement). Lyka Labs Limited originally initiated a Section 9 corporate insolvency application before the Ahmedabad bench of the National Company Law Tribunal (NCLT). However, the lower tribunal rejected the plea on hyper-technical grounds, asserting that Lyka Labs had failed to annex physical product invoices along with its statutory demand notice.
A three-member NCLAT appellate bench, led by Chairperson Justice Ashok Bhushan and technical members Barun Mitra and Arun Baroka, formally set aside the NCLT's decision. The appellate panel determined that because the debt arose directly out of a binding corporate contract, the presence or absence of separate transactional invoices could not be used by the debtor to circumvent insolvency law.
Contractual Violations and Financial Disagreement Context
Court documents reveal that Lyka Labs and Modi Lifecare Industries entered into a strategic Technical Guidance Agreement on September 14, 2012. Under the parameters of this pact:
The Obligation: Modi Lifecare secured permission to print product packaging and label cartons under the technical supervision branding of Lyka Labs.
The Royalty Structure: The agreement initially called for an annual minimum royalty commitment of ₹1 crore or 5% of gross sales, whichever was higher, which subsequently scaled up to a fixed minimum parameter of ₹2 crores annually.
The Default: After Modi Lifecare encountered financial constraints, the operational debt structured around these fixed commitments went unpaid.
While Lyka Labs argued that the guaranteed base sums were payable irrespective of volatile consumer market demand, Modi Lifecare countered that royalties should only track actual recorded sales. Despite arguing that the calculations were inconsistent, pre-litigation letters exchanged between the two corporate management teams showed that Modi Lifecare had explicitly admitted to an outstanding balance liability of roughly 6.3 million rupees.
Official Sources Section
The legal outcome has been confirmed via the certified case order distributed by the principal bench of the Insolvency and Bankruptcy Board of India. The parameters governing the compliance timeframe, case histories, and the application of Section 9 of the Insolvency and Bankruptcy Code (IBC) conform directly to the statutory documentation uploaded to the apex insolvency portal.
"According to officials from the appellate tribunal, the conditions required for the initiation of Section 9 corporate insolvency proceedings specifically the clear existence of an operational debt and a subsequent default were completely satisfied by the appellant."
Why It Matters
The ruling delivers immediate practical implications for corporate credit managers and legal advisors across India’s pharmaceutical and manufacturing landscapes. By confirming that an operational debt can be validated through contractual admissions and correspondence without the hyper-technical necessity of sequential invoices, the NCLAT has streamlined debt collection practices. For institutional investors tracking Lyka Labs, the cash infusion solidifies treasury balances, while for Modi Lifecare, it presents an immediate cash-flow burden to prevent a hostile operational takeover.
Key Facts at a Glance
The Order: Modi Lifecare must pay 6.3 million rupees to Lyka Labs Limited within a strict 30-day window.
The Legal Stakes: Failure to clear the ₹63 lakh operational balance within the specified timeframe will authorize the NCLT to admit Modi Lifecare into the Corporate Insolvency Resolution Process (CIRP).
Core Legal Precedent: The NCLAT ruled that physical invoices are not mandatory in demand notices if a default on a signed contract is explicitly admitted in written correspondence.
Origin of Debt: Unpaid royalty commitments stemming from a technical guidance partnership initially structured in September 2012.
FAQ Section
Q1: What did the tribunal order specify regarding Modi Lifecare?
A: The appellate tribunal directed Modi Lifecare Industries Limited to pay 6.3 million rupees (₹63 lakh) to Lyka Labs within 30 days to clear outstanding operational defaults.
Q2: Why did the lower NCLT bench initially reject Lyka Labs' insolvency plea?
A: The Ahmedabad NCLT bench dismissed the initial lawsuit because Lyka Labs did not append physical, itemized product invoices alongside the formal statutory demand notice sent to the debtor.
Q3: How did the NCLAT answer the invoice dispute?
A: The NCLAT noted that since the royalty liability was directly established by a Technical Guidance Agreement and acknowledged in subsequent balance letters, missing invoices did not invalidate the claim.
Q4: What happens if Modi Lifecare fails to pay the 6.3 million rupees on time?
A: If the payment deadline passes without compliance, the Adjudicating Authority is legally empowered to admit Modi Lifecare into insolvency under Section 9 of the IBC, halting normal corporate management controls.
Source: National Company Law Appellate Tribunal Principal Bench Judgments, indexed under Company Appeal (AT) (Insolvency) No. 726 of 2024 via the official Insolvency and Bankruptcy Board of India tracking system.
